|Articles|May 6, 2022

Phesi Global Analysis of 2.5 Million Patients Finds Participants in Breast Cancer Clinical Trials Are Getting Younger

New big data analysis finds growing proportion of younger participating in breast cancer clinical trials, with implications for trial design and execution.

New analysis from Phesi Inc. has found that since 2014 the number of women younger than 60 years of age participating in breast cancer clinical trials has increased dramatically, with an overall increase in trial participants younger than 60 years of age from 30% to about 80%. The results emerge following a global analysis of 2,511,046 breast cancer patients from 4,674 investigator sites.

Read more about the analysis from Phesi here.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!